Psychedelics Weekly – Prop 122 and Data Privacy, Ending the Crack/Cocaine Sentencing Disparity, and the High Cost of Psychedelic Therapy

December 23, 2022
Featuring: Joe Moore & Kyle Buller

Subscribe Share

In this week’s episode, Kyle is back on the podcast, joining Joe to discuss three recent articles; two of which pose a lot of questions. 

They first look at Colorado’s Proposition 122, which, now that it has passed, enters into the long and arduous process of being figured out – all while existing in the complicated paradigm of state vs. federal legality. One of the biggest concerns revolves around data collection and privacy: Is the collected data truly anonymous? Since psychedelics will still be federally illegal, how can we trust that the DEA isn’t going to abuse their power? 

Next, they discuss Attorney General Merrick Garland making moves to end the sentencing disparity between offenses involving powder cocaine and crack cocaine: while essentially the same substance, being caught with 28 grams of crack cocaine currently carries the same sentencing as having 500 grams of powder!  

And lastly, they touch on a very interesting article from Lucid News about the value of psychedelic therapy, which gives some staggering data points showing why the black market will always exist: MDMA-assisted therapy sessions likely costing $11,500 (with the MDMA itself costing between $480 and $9,600), Esketamine treatments costing as much as $32,400 a year, and more – all with results that don’t seem to be as long-lasting as many believed they would be. This one deserves more analysis, but Joe and Kyle had limited time for recording this week, so stay tuned for more. For now, enjoy this episode, and Happy Holidays from the Psychedelics Today team!

Links Big Questions Surround the Rollout of Psychedelics in Colorado Seeking Psychedelics? Check the Data Privacy Clause AG issues new guidance on ending sentencing disparities for crack versus powder cocaine cases PT236 – Drugs: Honesty, Responsibility, and Logic, featuring Dr. Carl Hart Is the High Cost of Psychedelic Therapy Worth It? Dennis McKenna — The Depths of Ayahuasca: 500+ Sessions, Fundamentals, Advanced Topics, Science, Churches, Learnings, Warnings, and Beyond (#523)


In this Episode

Joe Moore

CEO & Co-Founder

Kyle Buller (2)-min

Kyle Buller

Vice President of Education + Training & Co-Founder